The Coccidioidomycosis market report covers emerging drugs, current treatment practices, Coccidioidomycosis market share of the individual therapies, current and forecasted Coccidioidomycosis Market Size from 2017 to 2030 segmented by seven major markets.
The report also provides detailed current Coccidioidomycosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Coccidioidomycosis Market Key Facts
According to the Centers for Disease Control and Prevention, approximately 5-10% of people who get Valley fever will develop serious or long-term problems in their lungs. In 2017, there were 14,364 cases of Valley fever reported to the CDC.
As per the study conducted by McCotter et al., it was observed that the incidence of coccidioidomycosis increase steadily with age, with those over age 70 experiencing the highest rate at 209 cases per 100,000 population while the rate for those between 1 and 4 years of age is 7.7 per 100,000 population.
As per the study by Brown et al., titled “Coccidioidomycosis: epidemiology”, it was observed that Coccidioidomycosis has been more common among men than women may due to greater participation of men in high-risk activities or cigarette smoking. Certain human sex hormones stimulate the growth of Coccidioides in vitro, which may also contribute to the elevated incidence in males.
Visit For Sample Pages:
Key Benefits of Coccidioidomycosis Market Report
Coccidioidomycosis market report provides an in-depth analysis of Coccidioidomycosis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Coccidioidomycosis market report will help in developing business strategies by understanding the Coccidioidomycosis Market trends & developments, key players and future market competition that will shape and drive the Coccidioidomycosis market in the upcoming years.
The Coccidioidomycosis market report covers Coccidioidomycosis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Coccidioidomycosis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
The Coccidioidomycosis market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Coccidioidomycosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
The report gives a thorough detail of Coccidioidomycosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
The Coccidioidomycosis epidemiology section covers insights about historical and current Coccidioidomycosis patient pool and forecasted trend for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The Coccidioidomycosis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Coccidioidomycosis market or expected to get launched in the market during the study period. The analysis covers Coccidioidomycosis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions. Some of the emerging therapies in the Coccidioidomycosis market include Ibrexafungerp, VT-1598, APX001 and others. Scynexis, Mycovia Pharmaceuticals, Amplyx Pharmaceuticals, are some of the key players in the Coccidioidomycosis market.
Table of Contents
1. Key Insights
2. Executive Summary
3. Coccidioidomycosis Competitive Intelligence Analysis
4. Coccidioidomycosis Market Overview at a Glance
5. Coccidioidomycosis Disease Background and Overview
6. Coccidioidomycosis Patient Journey
7. Coccidioidomycosis Epidemiology and Patient Population
8. Coccidioidomycosis Treatment Algorithm, Current Treatment, and Medical Practices
9. Coccidioidomycosis Unmet Needs
10. Key Endpoints of Coccidioidomycosis Treatment
11. Coccidioidomycosis Marketed Products
12. Coccidioidomycosis Emerging Therapies
13. Coccidioidomycosis Seven Major Market Analysis
14. Attribute Analysis
15. Coccidioidomycosis Market Outlook (7 major markets)
16. Coccidioidomycosis Access and Reimbursement Overview
17. KOL Views on the Coccidioidomycosis Market.
18. Coccidioidomycosis Market Drivers
19. Coccidioidomycosis Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States